These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27347940)

  • 1. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
    Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
    PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
    Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
    Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
    Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
    Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
    Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
    Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of PBK/TOPK in cervical cancer and cervical intraepithelial neoplasia.
    Luo Q; Lei B; Liu S; Chen Y; Sheng W; Lin P; Li W; Zhu H; Shen H
    Int J Clin Exp Pathol; 2014; 7(11):8059-64. PubMed ID: 25550851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.
    Qiao L; Ba J; Xie J; Zhu R; Wan Y; Zhang M; Jin Z; Guo Z; Yu J; Chen S; Yao Y
    World J Surg Oncol; 2022 Sep; 20(1):316. PubMed ID: 36171591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer.
    Zhang Y; Yang X; Wang R; Zhang X
    J Cancer; 2019; 10(1):131-137. PubMed ID: 30662533
    [No Abstract]   [Full Text] [Related]  

  • 11. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
    Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
    Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PBK/TOPK in the differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma and its involvement in prognosis of human cholangiocarcinoma.
    He F; Yan Q; Fan L; Liu Y; Cui J; Wang J; Wang L; Wang Y; Wang Z; Guo Y; Huang G
    Hum Pathol; 2010 Mar; 41(3):415-24. PubMed ID: 19954816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PBK Expression Is Associated With Prognosis of Patients With Oral Squamous Cell Carcinoma Treated With Radiotherapy: A Retrospective Study.
    Yu WN; Lin HF; Lee YI; Shia WC; Sung WW; Yeh CM; Lin YM
    Anticancer Res; 2021 Apr; 41(4):2177-2182. PubMed ID: 33813430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression of PDZ-binding kinase/T-LAK cell-originated protein kinase modulates the invasive ability of human pancreatic cancer cells via the stabilization of oncoprotein c-MYC.
    Hinzman CP; Aljehane L; Brown-Clay JD; Kallakury B; Sonahara F; Goel A; Trevino J; Banerjee PP
    Carcinogenesis; 2018 Dec; 39(12):1548-1559. PubMed ID: 30165468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
    Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
    Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin suppresses lung cancer growth by targeting PDZ-binding kinase/T-LAK cell-originated protein kinase.
    Diao X; Yang D; Chen Y; Liu W
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30898980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
    Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
    Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
    Brown-Clay JD; Shenoy DN; Timofeeva O; Kallakury BV; Nandi AK; Banerjee PP
    Oncotarget; 2015 Jun; 6(17):15594-609. PubMed ID: 25909225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PBK/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21.
    Hu F; Gartenhaus RB; Eichberg D; Liu Z; Fang HB; Rapoport AP
    Oncogene; 2010 Oct; 29(40):5464-74. PubMed ID: 20622899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.